Abstract
Dendritic cells(DCs) are the most powerful antigen-presenting cells in the body, which has become a hot research topic in the field of tumor immunotherapy because of their pivotal role in the innate immune and adaptive immune response. Pulsed by tumor cells, tumor specific peptides and so on, DCs can induce T cells to effective cytotoxic T cells. The paper briefly reviews preclinical research and clinical treatment of DCs for immunotherapy in pancreatic cancer. Key words: Pancreatic neoplasms; Immunotherapy; Dendritic cells
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
